AI Powers Improved Breast Cancer Screening
Breast cancer is the most common form of cancer worldwide, and low rates of routine screening in China are a systemic challenge that leads to a higher incidence of diagnosis in later stages, which corresponds to lower cure rates. Scaling screening resources is complicated by the limited number of ultrasound radiologists, as well as the difficulty of serving highly distributed populations with limited access to clinical facilities. Developments in AI and machine learning promise to help address these systemic issues, enabling technology to act as a multiplier for screening capacity. iCare365 has advanced the field by developing “Dr. J,” an AI screening solution that works together with radiologists to analyze ultrasound scans. The solution is powered by 11th Gen Intel® Core™ processors with integrated Intel Iris® Xe graphics.